Legal & General Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Sell
131,755
-20,207
-13% -$283K ﹤0.01% 1995
2025
Q1
$2.07M Buy
151,962
+2,449
+2% +$33.3K ﹤0.01% 1908
2024
Q4
$3.05M Buy
149,513
+8,108
+6% +$165K ﹤0.01% 1808
2024
Q3
$4.12M Buy
141,405
+12,059
+9% +$351K ﹤0.01% 1663
2024
Q2
$3M Buy
129,346
+21,896
+20% +$508K ﹤0.01% 1766
2024
Q1
$2.2M Buy
107,450
+737
+0.7% +$15.1K ﹤0.01% 1900
2023
Q4
$2.29M Buy
106,713
+888
+0.8% +$19.1K ﹤0.01% 1880
2023
Q3
$2.18M Buy
105,825
+933
+0.9% +$19.2K ﹤0.01% 1860
2023
Q2
$3.1M Buy
104,892
+7,274
+7% +$215K ﹤0.01% 1713
2023
Q1
$2.25M Buy
97,618
+2,603
+3% +$60K ﹤0.01% 1835
2022
Q4
$2.64M Buy
95,015
+8,998
+10% +$250K ﹤0.01% 1742
2022
Q3
$2.64M Sell
86,017
-486
-0.6% -$14.9K ﹤0.01% 1711
2022
Q2
$2.55M Buy
86,503
+7,077
+9% +$208K ﹤0.01% 1763
2022
Q1
$2.56M Buy
79,426
+455
+0.6% +$14.6K ﹤0.01% 1875
2021
Q4
$3.52M Buy
78,971
+1,443
+2% +$64.4K ﹤0.01% 1761
2021
Q3
$3.91M Buy
77,528
+15,284
+25% +$771K ﹤0.01% 1684
2021
Q2
$4.88M Buy
62,244
+18,694
+43% +$1.47M ﹤0.01% 1543
2021
Q1
$2.49M Sell
43,550
-1,347
-3% -$76.9K ﹤0.01% 1885
2020
Q4
$3.76M Buy
44,897
+5,311
+13% +$445K ﹤0.01% 1612
2020
Q3
$1.42M Buy
39,586
+4,832
+14% +$173K ﹤0.01% 1915
2020
Q2
$840K Buy
34,754
+8,476
+32% +$205K ﹤0.01% 2034
2020
Q1
$460K Sell
26,278
-1,381
-5% -$24.2K ﹤0.01% 2092
2019
Q4
$482K Buy
27,659
+1,861
+7% +$32.4K ﹤0.01% 2226
2019
Q3
$395K Hold
25,798
﹤0.01% 2211
2019
Q2
$536K Buy
25,798
+490
+2% +$10.2K ﹤0.01% 2131
2019
Q1
$587K Buy
25,308
+16,670
+193% +$387K ﹤0.01% 2120
2018
Q4
$179K Buy
8,638
+1,212
+16% +$25.1K ﹤0.01% 2332
2018
Q3
$162K Sell
7,426
-6,554
-47% -$143K ﹤0.01% 2380
2018
Q2
$213K Sell
13,980
-37,756
-73% -$575K ﹤0.01% 2283
2018
Q1
$1.02M Buy
51,736
+51,681
+93,965% +$1.02M ﹤0.01% 1881
2017
Q4
$1K Buy
+55
New +$1K ﹤0.01% 3280